CD40/CD40 Ligand Interactions in Normal, Reactive and Malignant Lympho-Hematopoietic Tissues

References

• Clark E. A., Ledbetter J. A. Activation of human B cells mediated through two distinct cell surface differentiation antigens, Bp35 and Bp50. Proc. Natl. Acad. Sci. USA 1986; 83: 4494–4498
   PubMed Web of Science ®Google Scholar
• Stamenkovic I., Clark E. A., Seed B. A B-lymphocyte activation molecule related to the nerve growth factor receptor and induced by cytokines in carcinomas. EMBO J. 1989; 8: 1403–1410
   PubMed Web of Science ®Google Scholar
• Smith C. A., Farrah T., Goodwin R. G. The TNF receptor superfamily of cellular and viral proteins: activation, costimulation, and death. Cell 1994; 75: 959–962
   Web of Science ®Google Scholar
• Banchereau J., Bazan F., Blanchard D., Briere F., Galizzi J.-P., van Kooten C., Liu Y. J., Rousset F., Saeland S. The CD40 antigen and its ligand. Annu. Rev. Immunol. 1994; 12: 881–922
   PubMed Web of Science ®Google Scholar
• Gruss H.-J., Dower S. K. TNF ligand superfamily: involvement in the pathology of malignant lymphomas. Blood 1995; 85: 3378–3404
   PubMed Web of Science ®Google Scholar
• Torres R. M., Clark E. A. Differential increase of an alternatively polyadenylated mRNA species of murine CD40 upon B lymphocyte activation. J. Immunol. 1992; 148: 620–628
   PubMed Web of Science ®Google Scholar
• Mallett S., Barclay A. N. A new superfamily of cell surface proteins related to the nerve growth factor receptor. Immunol. Today 1991; 12: 220–223
   PubMedGoogle Scholar
• Bazan J. F. Emerging families of cytokines and receptors. Curr. Biol. 1993; 3: 603–606
   PubMed Web of Science ®Google Scholar
• Banner D. W., D'Arcy A., Janes W., Gentz R., Schoenfeld H.-J., Broger C., Loetscher H., Lesslauer W. Crystal structure of the soluble human 55 kd TNF receptor-human TNFβ complex: implications for TNF receptor activation. Cell 1993; 73: 431–445
   PubMed Web of Science ®Google Scholar
• Grimaldi J. C., Torres R., Kozak C. A., Chang R., Clark E. A., Howard M., Cockayne D. A. Genomic structure and chromosomal mapping of the murine CD40 gene. J. Immunol. 1992; 149: 3921–3926
   PubMed Web of Science ®Google Scholar
• Ramesh N., Ramesh V., Gusella J. F., Geha R. Chromosomal localization of the gene for human B cell antigen CD40. Somatic Cell. Mol. Gen. 1993; 19: 295–298
   PubMedGoogle Scholar
• Lafage-Poitchaloff M., Herman P., Birg F., Galizzi J. P., Simonetti J., Mannoni P., Banchereau J. Localization of the human CD40 gene to chromosome 20. bands q12-q13.2. Leukemia 1994; 8: 1172–1175
   PubMed Web of Science ®Google Scholar
• Feinstein E., Kimchi A., Wallach D., Boldin M., Varfolomeev E. The death domain: a module shared by proteins with diverse cellular functions. Trends Biolog. Sci. 1995; 20: 342–344
   PubMed Web of Science ®Google Scholar
• Itoh N., Nagata S. A novel protein domain required for apoptosis. Mutational analysis of human Fas antigen. J. Biol. Chem. 1993; 268: 10932–10937
   PubMed Web of Science ®Google Scholar
• Tartaglia L. A., Ayres T. M., Wong G. H. W., Goeddel D. V. A novel domain within the 55 kd TNF receptor signals cell death. Cell 1993; 74: 845–853
   PubMed Web of Science ®Google Scholar
• Gravestein L. A., Blorn B., Nolten L. A., de Vries E., van der Horst G., Ossendorp F., Borst J., Loenen W. A. M. Cloning and expression of murine CD27: comparison with 4-1BB, another lymphocyte-specific member of the nerve growth factor receptor family. Eur. J. Immunol. 1993; 23: 943–950
   PubMed Web of Science ®Google Scholar
• Vandenabeele P., Declercq W., Beyaert R., Fiers W. Two tumour necrosis factor receptors: structure and function. Trends Cell. Biol. 1995; 5: 392–399
   PubMed Web of Science ®Google Scholar
• Mosialos G., Birkenbach M., Yalamanchili R., VanArsdale T., Ware C., Kieff E. The Epstein-Barr virus transforming protein LMP1 engages signaling proteins for the tumor necrosis factor receptor family. Cell 1995; 80: 389–399
   PubMed Web of Science ®Google Scholar
• Hu H. M., O'Rourke K., Boguski M. S., Dixit V. M. A novel RING finger protein interacts with the cytoplasmic domain of CD40. J. Biol. Chem. 1994; 269: 30069–30072
   PubMed Web of Science ®Google Scholar
• Rothe M., Sarma V., Dixit V. M., Goeddel D. V. TRAF2-mediated activation of NF-B by TNF receptor 2 and CD40. Science 1995; 269: 1424–1427
   PubMed Web of Science ®Google Scholar
• Ware C. F., VanArsdale S., VanArsdale T. L. Apoptosis mediated by the TNF-related cytokine and receptor families. J. Cell. Biochem. 1996; 60: 47–55
   PubMed Web of Science ®Google Scholar
• Uckun F. M., Schieven G. L., Diberdik I., Chandan-Langlie M., Tuel-Ahlgren L., Ledbetter J. A. Stimulation of protein tyrosine phosphorylation, phosophoinositide turnover, and multiple previously unidentified serine/threonine-specific protein kinases by the pan-B-cell receptor CD40/Bp50 at discrete developmental stages of human B-cell ontogeny. J. Biol. Chem. 1991; 266: 17478–17485
   PubMed Web of Science ®Google Scholar
• Inui S., Kaisho T., Kikutani H., Stamenkovic I., Seed B., Clark E. A., Kishimoto T. Identification of the intracytoplasmic region essential for signal transduction through a B cell activation molecule, CD40. Eur. J. Immunol. 1990; 20: 1747–1753
   PubMed Web of Science ®Google Scholar
• Kansas G. S., Tedder T. F. Transmembrane signals generated through MHC class II, CD19, CD20, CD39, and CD40 antigens induce LFA-1-dependent and independent adhesion in human B cells through a tyrosine kinase-dependent pathway. J. Immunol. 1991; 147: 4094–4102
   PubMed Web of Science ®Google Scholar
• Ren C. L., Morio T., Fu S. F., Geha R. S. Signal transduction via CD40 involves activation of lyn kinase and phosphatidylinositol-3-kinase, and phosphorylation of phospholipase Cγ2. J. Exp. Med. 1994; 179: 673–680
   PubMed Web of Science ®Google Scholar
• Knox K. A., Gordon J. Protein tyrosine phosphorylation is mandatory for CD40-mediated rescue of germinal center B cells from apoptosis. Eur. J. Immunol. 1993; 23: 2578–2584
   PubMed Web of Science ®Google Scholar
• Faris M., Gaskin F., Parsons T., Fu S. M. CD40 signaling pathway: anti-CD40 monoclonal antibody induces rapid dephosphorylation and phosphorylation of tyrosine-phosphorylated proteins including protein tyrosine kinase lyn. fyn. and syk and the appearance of a 28-kD tyrosine phosphorylated protein. J. Exp. Med. 1994; 179: 1923–1931
   PubMed Web of Science ®Google Scholar
• Berberich I., Shu G., Siebelt F., Woodgett J. R., Kyriakis J. M., Clark E. A. Cross-linking CD40 on B cells preferentially induces stress-activated protein kinases rather than mitogen-activated protein kinases. EMBO J. 1996; 15: 92–101
   PubMed Web of Science ®Google Scholar
• Berberich I., Shu G. L., Clark E. A. Cross-linking CD40 on B cells rapidly activates nuclear factor-B. J. Immunol. 1994; 153: 4357–4366
   PubMed Web of Science ®Google Scholar
• Francis D. A., Karras J. G., Ke X., Sen R., Rothstein T. L. Induction of the transcription factors NF-kappaB, AP-1 and NF-AT during B cell stimulation through the CD40 receptor. Int. Immunol. 1995; 7: 151–161
   PubMed Web of Science ®Google Scholar
• Clark E. A., Ledbetter J. A. How B and T cells talk to each other. Nature 1994; 367: 425–428
   PubMed Web of Science ®Google Scholar
• Armitage R. J., Fanslow W. C., Strockbine L., Sato T. A., Clifford K. N., Macduff B. M., Anderson D. M., Gimpel S. D., Davis-Smith T., Maliszewski C. R., Clark E. A., Smith C. A., Grabstein K. H., Cosman D., Spriggs M. K. Molecular and biological characterization of a murine ligand for CD40. Nature 1992; 357: 80–82
   PubMed Web of Science ®Google Scholar
• Spriggs M. K., Armitage R. J., Strockbine L., Clifford K. N., Macduff B. M., Sato T. A., Maliszewski C. R., Fanslow W. C. Recombinant human CD40 ligand stimulates B cell proliferation and Immunoglobulin E secretion. J. Exp. Med. 1992; 176: 1543–1550
   PubMed Web of Science ®Google Scholar
• Hollenbaugh D., Grosmaire L. S., Kullas C. D., Chalupny N. J., Braesch-Andersen S., Noelle R. J., Stamenkovic I., Ledbetter J. A., Aruffo A. The human T cell antigen gp39, a member of the TNF gene family, is a ligand for the CD40 receptor: expression of a soluble form of gp39 with B cell co-stimulatory activity. EMBO J. 1992; 11: 4313–4321
   PubMed Web of Science ®Google Scholar
• Gauchat J. F., Aubry J. P., Mazzei G., Life P., Jomotte T., Elson G., Bonnefoy J. Y. Human CD40-ligand: molecular cloning, cellular distribution and regulation of expression by factors controlling IgE production. FEBS Lett. 1993; 315: 259–266
   PubMed Web of Science ®Google Scholar
• Graf D., Korthäuer U., Mages H. W., Senger G., Kroczek R. A. Cloning of TRAP, a ligand for CD40 on human T cells. Eur. J. Immunol. 1992; 22: 3191–3194
   PubMed Web of Science ®Google Scholar
• Cocks B. G., de Waal Malefyt R., Galizzi J. P., de Vries J. E., Aversa G. IL-13 induces proliferation and differentiation of human B cells activated by the CD40 ligand. Int. Immunol. 1993; 5: 657–663
   PubMed Web of Science ®Google Scholar
• Lane P., Traunecker A., Hubele S., Inui S., Lanzavecchia A., Gray D. Activated human T cells express a ligand for the human B cell-associated antigen CD40 which participates in T cell-dependent activation of B lymphocytes. Eur. J. Immunol. 1992; 22: 2573–2578
   PubMed Web of Science ®Google Scholar
• Graf D., Mñller S., Korthäuer U., van Kooten C., Weise C., Kroczek R. A. A soluble form of TRAP (CD40 ligand) is rapidly released after T cell activation. Eur. J. Immunol. 1995; 25: 1749–1754
   PubMed Web of Science ®Google Scholar
• Jones E. Y., Stuart D. I., Walker N. P. C. Structure of tumour necrosis factor. Nature 1989; 338: 225–228
   PubMed Web of Science ®Google Scholar
• Peitsch M. C., Jongeneel C. V. A 3-D model for the CD40 ligand predicts that it is a compact trimer similar to the tumor necrosis factors. Int. Immunol. 1993; 5: 233–238
   PubMed Web of Science ®Google Scholar
• Karpusas M., Hsu Y.-M., Wang J.-H., Thompson J., Lederman S., Chess L., Thomas D. 2Å crystal structure of an extracellular fragment of human CD40 ligand. Structure 1995; 3: 1031–1039
   PubMed Web of Science ®Google Scholar
• Wiley S. R., Schooley K., Smolak P. J., Din W. S., Huang C.-P., Nicholl J. K., Sutherland G. R., Smith T. D., Rauch C., Smith C. A., Goodwin R. G. Identification and characterization of a new member of the TNF family that induces apoptosis. Immunity 1995; 3: 673–682
   PubMed Web of Science ®Google Scholar
• Browning J. L., Ngam-Ek A., Lawton P., DeMarinis J., Tizard R., Chow E. P., Hession C., O'Brien-Greco B., Foley S. F., Ware C. F. Lymphotoxin β, a novel member of the TNF family that forms a heteromeric complex with lymphotoxin on the cell surface. Cell 1993; 72: 847–856
   PubMed Web of Science ®Google Scholar
• Crowe P. D., VanArsdale T. L., Walter B. N., Ware C. F., Hession C., Ehrenfels B., Browning J. L., Din W. S., Goodwin R. G., Smith C. A. A lymphotoxin-β-specific receptor. Science 1994; 264: 707–710
   PubMed Web of Science ®Google Scholar
• Pennica D., Nedwin G. E., Hayflick J. S., Seeburg P. H., Derynck R., Palladino M. A., Kohr W. J., Aggarwal B. B., Goeddel D. V. Human tumour necrosis factor: precursor structure, expression and homology to lymphotoxin. Nature 1984; 312: 724–729
   PubMed Web of Science ®Google Scholar
• Suda T., Takahashi T., Golstein P., Nagata S. Molecular cloning and expression of the Fas ligand, a novel member of the tumor necrosis factor family. Cell 1993; 75: 1169–1178
   PubMed Web of Science ®Google Scholar
• Gruss H.-J., Herrmann F. CD30 ligand, a member of the TNF ligand superfamily, with growth and activation control for CD30+ lymphoid and lymphoma cells. Leuk. Lymphoma 1996; 20: 387–409
   Web of Science ®Google Scholar
• Kriegler M., Perez C., DeFay K., Albert I., Lu S. D. A novel form of TNF/cachectin is a cell surface cytotoxic transmembrane protein: ramifications for the complex physiology of TNF. Cell 1988; 53: 45–53
   PubMed Web of Science ®Google Scholar
• Gray P. W., Aggarwal B. B., Benton C. V., Bringman T. S., Henzel W. J., Jarrett J. A., Leung D. W., Moffat B., Ng P., Svedersky L. P., Palladino M. A., Nedwin G. E. Cloning and expression of cDNA for human lymphotoxin, a lymphokine with tumour necrosis activity. Nature 1984; 312: 721–724
   PubMed Web of Science ®Google Scholar
• Tanaka M., Suda T., Takahashi T., Nagata S. Expression of the functional soluble form of human FAS ligand in activated lymphocytes. EMBO J. 1995; 14: 1129–1135
   PubMed Web of Science ®Google Scholar
• Allen R. C., Armitage R. J., Conley M. E., Rosenblatt H., Jenkins N. A., Copeland N. G., Bedell M. A., Edelhoff S., Disteche C. M., Simoneaux D. K., Fanslow W. C., Belmont J., Spriggs M. K. CD40 ligand gene defects responsible for X-linked hyper-IgM syndrome. Science 1993; 259: 990–993
   PubMed Web of Science ®Google Scholar
• Aruffo A., Farrington M., Hollenbaugh D., Li X., Milatovich A., Nonoyama S., Bajorath J., Grosmaire L. S., Stenkamp R., Neubauer M., Roberts R. L., Noelle R. J., Ledbetter J. A., Francke U., Ochs H. D. The CD40 ligand, gp39, is defective in activated T cells from patients with X-linked hyper-IgM syndrome. Cell 1993; 72: 291–300
   PubMed Web of Science ®Google Scholar
• Callard R. E., Armitage R. J., Fanslow W. C., Spriggs M. K. CD40 ligand and its role in X-linked hyper-IgM syndrome. Immunol. Today 1993; 14: 559–564
   PubMedGoogle Scholar
• Conley M. E. Molecular approaches to analysis of X-linked immunodeficiencies. Annu. Rev. Immunol. 1992; 10: 215–238
   PubMed Web of Science ®Google Scholar
• Padayachee M., Feighery C., Finn A., McKeown C., Levinsky R. J., Kinnon C., Malcolm S. Mapping of the X-linked form of hyper-IgM syndrome (HIGM1) to Xq26 by close linkage to HPRT. Genomics 1992; 14: 551–553
   PubMed Web of Science ®Google Scholar
• Fuleihan R., Ramesh N., Loh R., Jabara H., Rosen R. S., Chatila T., Fu S. M., Stamenkovic I., Geha R. S. Defective expression of the CD40 ligand in X chromosome-linked immunoglobulin deficiency with normal or elevated IgM. Proc. Natl. Acad. Sci. USA 1993; 90: 2170–2173
   PubMed Web of Science ®Google Scholar
• Korthäuer U., Graf D., Mages H. W., BriéGre F., Padayachee M., Malcolm S., Ugazio A. G., Notarangelo L. D., Levinsky R. J., Kroczek R. A. Defective expression of T-cell CD40 ligand causes X-linked immunodeficiency with hyper IgM. Nature 1993; 361: 539–541
   PubMed Web of Science ®Google Scholar
• DiSanto J. P., Bonnefoy J. Y., Gauchat J. F., Fischer A., de Saint Basile G. CD40 ligand mutations in X-linked immunodeficiency with hyper-IgM. Nature 1993; 361: 541–543
   PubMed Web of Science ®Google Scholar
• Kawabe T., Naka T., Yoshida K., Tanaka T., Fujiwara H., Suematsu S., Yoshida N., Kishimoto T., Kikutani H. The immune responses in CD40-deficient mice: impaired immunoglobulin class switching and germinal center formation. Immunity 1994; 1: 167–178
   PubMed Web of Science ®Google Scholar
• Renshaw B., Fanslow W. C., Armitage R. J., Campbell K. A., Liggitt D., Wright B., Davison B., Maliszewski C. R. Humoral immune responses in CD40 ligand deficient mice. J. Exp. Med. 1994; 180: 1889–1900
   PubMed Web of Science ®Google Scholar
• Xu J., Foy T. M., Laman J. D., Elliott E. A., Dunn J. J., Waldschmidt T. J., Elsemore J., Noelle R. J., Flavell R. A. Mice deficient for the CD40 ligand. Immunity 1994; 1: 423–431
   PubMed Web of Science ®Google Scholar
• Foy T. M., Shepherd D. M., Durie F. H., Aruffo A., Ledbetter J. A., Noelle R. J. In vivo CD40-gp39 interactions are essential for thymus-dependent humoral immunity. II. Prolonged suppression of the humoral immune response by an antibody to the ligand for CD40, gp39. J. Exp. Med. 1993; 178: 1567–1575
   PubMed Web of Science ®Google Scholar
• Foy T. M., Laman J. D., Ledbetter J. A., Aruffo A., Claassen E., Noelle R. J. gp39-CD40 interactions are essential for germinal center formation and the development of B cell memory. J. Exp. Med. 1994; 180: 157–163
   PubMed Web of Science ®Google Scholar
• Gray D., Dullforce P., Jainandunsing S. Memory B cell development but not germinal center formation is impaired by in vivo blockage of CD40-CD40L interaction. J. Exp. Med. 1994; 180: 141–155
   PubMed Web of Science ®Google Scholar
• Gray D., Siepmann K., Wohlleben G. CD40 ligation in B cell activation, isotype switching and memory development. Semin. Immunol. 1994; 6: 303–310
   PubMedGoogle Scholar
• Liu Y. J., de Bouteiller O., Arpin C., Durand I., Banchereau J. Five human mature B cell subsets. Adv. Exp. Med. Biol. 1993; 355: 289–296
   Google Scholar
• Quiding-Jarbrink M., Lakew M., Nordstrom I., Banchereau J., Butcher E., Holmgren J., Czerkinsky C. Human circulating specific antibody-forming cells after systemic and mucosal immunizations: differential homing commitments and cell surface differentiation markers. Eur. J. Immunol. 1995; 25: 322–327
   PubMed Web of Science ®Google Scholar
• Ledbetter J. A., Shu G., Gallagher M., Clark E. A. Augmentation of normal and malignant B cell proliferation by monoclonal antibody to the B cell-specific antigen BP50 (CDW40). J. Immunol. 1987; 138: 788–794
   PubMed Web of Science ®Google Scholar
• Valle A., Zuber C. E., Defrance T., Djossou O., DeRie M., Banchereau J. Activation of human B lymphocytes through CD40 and interleukin 4. Eur. J. Immunol. 1989; 19: 1463–1467
   PubMed Web of Science ®Google Scholar
• Uckun F. M., Gajl-Peczalska K., Myers D. E., Jaszcz W., Haissig S., Ledbetter J. A. Temporal association of CD40 antigen expression with discrete stages of human B-cell ontogeny and the efficacy of anti-CD40 immunotoxins against clonogenic B-lineage acute lymphoblastic leukemia as well as B-lineage non-Hodgkin's lymphoma cells. Blood 1990; 76: 2449–2456
   PubMed Web of Science ®Google Scholar
• Law C.-L., Wörmann B., LeBien T. W. Analysis of expression and function of CD40 on normal and leukemic human B cell precursors. Leukemia 1990; 4: 732–738
   PubMed Web of Science ®Google Scholar
• Paulie S., Ehlin-Henriksson B., Mellstedt H., Koho H., Ben-Aissa H., Perlmann P. A p50 surface antigen restricted to human urinary bladder carcinomas and B lymphocytes. Cancer Immunol. Immunother. 1985; 20: 23–28
   PubMed Web of Science ®Google Scholar
• van Kooten C., Gaillard C., Galizzi J.-P., Hermann P., Fossiez F., Banchereau J., Blanchard D. B cells regulate expression of CD40 ligand on activated T cells by lowering the mRNA level and through the release of soluble CD40. Eur. J. Immunol. 1994; 24: 787–792
   PubMed Web of Science ®Google Scholar
• Gordon J., Millsum M. J., Guy G. R., Ledbetter J. A. Resting B lymphocytes can be triggered directly through the CDw40 (Bp50) antigen. J. Immunol. 1988; 140: 1425–1430
   PubMed Web of Science ®Google Scholar
• Björck P., Axelsson B., Paulie S. Expression of CD40 and CD43 during activation of human B lymphocytes. Scand. J. Immunol. 1991; 33: 211–218
   PubMed Web of Science ®Google Scholar
• Kansas G. S., Wood G. S., Tedder T. F. Expression, distribution, and biochemistry of human CD39. Role in activation-associated homotypic adhesion of lymphocytes. J. Immunol. 1991; 146: 2235–2344
   PubMed Web of Science ®Google Scholar
• Barrett T. B., Shu G., Clark E. A. CD40 signaling activates CD11a/CD18 (LFA-1)-mediated adhesion in B cells. J. Immunol. 1991; 146: 1722–1729
   PubMed Web of Science ®Google Scholar
• Flores-Romo L., Estoppey D., Bacon K. B. Anti-CD40 antibody stimulates the VLA-4-dependent adhesion of normal and LFA-1-deficient B cells to endothelium. Immunol. 1993; 79: 445–451
   PubMed Web of Science ®Google Scholar
• Liu Y.-J., Joshua D. E., Williams G. T., Smith C. A., Gordon J., MacLennan I. C. M. Mechanism of antigen-driven selection in germinal centres. Nature 1989; 342: 929–931
   PubMed Web of Science ®Google Scholar
• Liu Y. J., Mason D. Y., Johnson G. D., Abbot S., Gregory C. D., Hardie D. L., Gordon J., MacLennan I. C. Germinal center cells express bcl-2 protein after activation by signals which prevent their entry into apoptosis. Eur. J. Immunol. 1991; 21: 1905–1910
   PubMed Web of Science ®Google Scholar
• Holder M. J., Wang H., Milner A. E., Casamayor M., Armitage R., Spriggs M. K., Fanslow W. C., MacLennan I. C. M., Gregory C. D., Gordon J. Suppression of apoptosis in normal and neoplastic human B lymphocytes by CD40 ligand is independent of Bcl-2 induction. Eur. J. Immunol. 1993; 23: 2368–2371
   PubMed Web of Science ®Google Scholar
• Grabstein K. H., Maliszewski C. R., Shanebeck K., Sato T. A., Spriggs M. K., Fanslow W. C., Armitage R. J. The regulation of T cell-dependent antibody formation in vitro by CD40 ligand and IL-2. J. Immunol. 1993; 150: 3141–3147
   PubMed Web of Science ®Google Scholar
• Lederman S., Yellin M. J., Krichevsky A., Belko J., Lee J. J., Chess L. Identification of a novel surface protein on activated CD4+ T cells that induces contact-dependent B cell differentiation (help). J. Exp. Med. 1992; 175: 1091–1101
   PubMed Web of Science ®Google Scholar
• Armitage R. J., Macduff B. M., Spriggs M. K., Fanslow W. C. Human B cell proliferation and Ig secretion induced by recombinant CD40 ligand are modulated by soluble cytokines. J. Immunol. 1993; 150: 3671–3680
   PubMed Web of Science ®Google Scholar
• Ranheim E. A., Kipps T. J. Activated T cells induce expression of B7/BB1 on normal or leukemic B cells through a CD40-dependent signal. J. Exp. Med. 1993; 177: 925–935
   PubMed Web of Science ®Google Scholar
• Maliszewski C. R., Grabstein K., Fanslow W. C., Armitage R., Spriggs M. K., Sato T. A. Recombinant CD40 ligand stimulation of murine B cell growth and differentiation: cooperative effects of cytokines. Eur. J. Immunol. 1993; 23: 1044–1049
   PubMed Web of Science ®Google Scholar
• Kennedy M. K., Mohler K. M., Shanebeck K. D., Baum P. R., Picha K. S., Otten-Evans C. A., Janeway C. A., Grabstein K. H. Induction of B cell costimulatory function by recombinant murine CD40 ligand. Eur. J. Immunol. 1994; 24: 116–123
   PubMed Web of Science ®Google Scholar
• Clark E. A., Shu G. Association between IL-6 and CD40 signaling. IL-6 induces phosphorylation of CD40 receptors. J. Immunol. 1990; 145: 1400–1406
   PubMed Web of Science ®Google Scholar
• Burdin B., Peronne C., Banchereau J., Rousset F. Epstein-Barr virus-transformation induces B lymphocytes to produce human interleukin-10. J. Exp. Med. 1993; 177: 295–304
   PubMed Web of Science ®Google Scholar
• Worm M., Geha R. S. CD40 ligation induces lymphotoxin α gene expression in human B cells. Int. Immunol. 1994; 6: 1883–1890
   PubMed Web of Science ®Google Scholar
• Banchereau J., de Paoli P., Vallé A., Garcia E., Rousset F. Long-term human B cell lines dependent on interleukin-4 and antibody to CD40. Science 1991; 251: 70–72
   PubMed Web of Science ®Google Scholar
• Heath A. W., Chang R., Harada N., Santo-Sargumedo L., Gordon J., Hannum C., Campbell D., Shanafelt A. B., Clark E. A., Torres R., Howard M. Antibodies to murine CD40 stimulate normal B lymphocytes but inhibit proliferation of B lymphoma cells. Cell. Immunol. 1993; 152: 468–480
   PubMed Web of Science ®Google Scholar
• Defrance T., Vanbervliet B., Durand I., Briolay J., Banchereau J. Proliferation and differentiation of human CD5+ and CD5- B cell subsets activated through their antigen receptors or CD40 antigens. Eur. J. Immunol. 1992; 22: 2831–2839
   PubMed Web of Science ®Google Scholar
• Fluckiger A. C., Rossi J. F., Bussel A., Bryon P., Banchereau J., Defrance T. Responsiveness of chronic lymphocytic leukemia B cells activated via surface Igs or CD40 to B-cell tropic factors. Blood 1992; 80: 3173–3181
   PubMed Web of Science ®Google Scholar
• Rousset F., Garcia E., Banchereau J. Cytokine-induced proliferation and immunoglobulin production of human B lymphocytes triggered through their CD40 antigen. J. Exp. Med. 1991; 173: 705–710
   PubMed Web of Science ®Google Scholar
• Defrance T., Vanbervliet B., Brière F., Durand I., Rousset F., Banchereau J. Interleukin 10 and transforming growth factor β cooperate to induce anti-CD40-activated naive human B cells to secrete immunoglobulin A. J. Exp. Med. 1992; 175: 671–682
   PubMed Web of Science ®Google Scholar
• Gascan H., Gauchaf J.-F., Roncarolo M. G., Yssel H., Spits H., de Vries J. E. Human B cell clones can be induced to proliferate and switch to IgE and IgG4 synthesis by IL-4 and a signal provided by activated CD4+ T cell clones. J. Exp. Med. 1990; 173: 747–750
   Web of Science ®Google Scholar
• Shapira S. K., Vercelli D., Jabara H. H., Fu S. M., Geha R. S. Molecular analysis of the induction of immunoglobulin E synthesis in human B cell by interleukin 4 and engagement of CD40 antigen. J. Exp. Med. 1992; 175: 289–292
   PubMed Web of Science ®Google Scholar
• Gauchat J. F., Aversa G., Gascan H., de Vries J. E. Modulation of IL-4 induced germline epsilon RNA synthesis in human B cells by tumor necrosis factor-alpha, anti-CD40 monoclonal antibodies or transforming growth factor-beta correlates with levels of IgE production. Int. Immunol. 1992; 4: 397–406
   PubMed Web of Science ®Google Scholar
• Punnonen J., Aversa G. G., Cocks B. G., McKenzie A. N. J., Menon S., Zurawski G., de Waal Malefyt R., de Vries J. E. Interleukin-13 induces interleukin-4-independent IgG4 and IgE synthesis and CD23 expression by human B cells. Proc. Natl. Acad. Sci. USA 1993; 90: 3730–3734
   PubMed Web of Science ®Google Scholar
• Rousset F., Garcia E., Defrance T., Péronne C., Vezzio N., Hsu D.-H., Kastelein R., Moore K. W., Banchereau J. Interleukin 10 is a potent growth and differentiation factor for activated human B lymphocytes. Proc. Natl. Acad. Sci. USA 1992; 89: 1890–1893
   PubMed Web of Science ®Google Scholar
• Briere F., Servet-Delprat C., Bridon J.-M., Saint-Remy J.-M., Banchereau J. Human interleukin 10 induces naive sIgD+ B cells to secrete IgG1 and IgG3. J. Exp. Med. 1994; 179: 757–762
   PubMed Web of Science ®Google Scholar
• Coffman R. L., Lebman D. A., Shrader B. Transforming growth factor β specifically enhances IgA production by lipopolysaccharide-stimulated murine B lymphocytes. J. Exp. Med. 1989; 170: 1039–1045
   PubMed Web of Science ®Google Scholar
• Parker D. C. T cell-dependent B cell activation. Annu. Rev. Immunol. 1993; 11: 331–360
   PubMed Web of Science ®Google Scholar
• Noelle R. J., Snow E. C. Cognate interactions between helper T cells and B cells. Immunol. Today 1990; 11: 361–368
   PubMedGoogle Scholar
• Lipsky P. E. The induction of human B-cell activation, proliferation and differentiation by anti-CD3-stimulated T cells: A model of T cell/B cell collaboration. Res. Immunol. 1990; 141: 424–427
   PubMedGoogle Scholar
• Noelle R. J., McCann J., Marshall L., Bartlett W. C. Cognate interactions between helper B cells and B cells. III. Contact-dependent, lymphokine-independent induction of B cell cycle entry by activated helper T cells. J. Immunol. 1989; 143: 1807–1814
   PubMed Web of Science ®Google Scholar
• Noelle R. J., Roy M., Shepherd D. M., Stamenkovic I., Ledbetter J. A., Aruffo A. A 39-kDa protein on activated helper T cells binds CD40 and transduces the signal for cognate activation of B cells. Proc. Natl. Acad. Sci. USA 1992; 89: 6550–6554
   PubMed Web of Science ®Google Scholar
• Splawski J. B., Fu S. M., Lipsky P. E. Immunoregulatory role of CD40 in human B cell differentiation. J. Immunol. 1993; 150: 1276–1285
   PubMed Web of Science ®Google Scholar
• Notarangelo L. D., Duse M., Ugazio A. G. Immunodeficiency with hyper-IgM (HIM). Immunodefic. Rev. 1992; 3: 101–121
   PubMedGoogle Scholar
• Facchetti F., Appiani C., Salvi L., Levy J., Notarangelo L. D. Immunohistologic analysis of ineffective CD40-CD40 ligand interaction in lymphoid tissues from patients with X-linked immunodeficiency with hyper-IgM. Abortive germinal center cell reaction and severe depletion of follicular dendritic cells. J. Immunol. 1995; 154: 6624–6633
   PubMed Web of Science ®Google Scholar
• Saiki O., Tanaka T., Wada Y., Uda H., Inoue A., Katada Y., Izeki M., Iwata M., Nunoi H., Matsuda I., Kinoshita N., Kishimoto T. Signaling through CD40 rescues IgE but not IgG or IgA secretion in X-linked immunodeficiency with hyper-IgM. J. Clin. Invest. 1995; 95: 510–514
   PubMed Web of Science ®Google Scholar
• Durandy A., Schiff C., Bonnefoy J. Y., Forveille M., Rousset F., Mazzei G., Milili M., Fischer A. Induction by anti-CD40 antibody or soluble CD40 ligand and cytokines of IgG, IGa and IgE production by B cells from patients with X-linked hyper-IgM syndrome. Eur. J. Immunol. 1993; 23: 2294–2299
   PubMed Web of Science ®Google Scholar
• Castle B. E., Kishimoto K., Stearns C., Brown M. L., Kehry M. R. Regulation of expression of the ligand for CD40 on T helper lymphocytes. J. Immunol. 1993; 151: 1777–1788
   PubMed Web of Science ®Google Scholar
• Roy M., Waldschmidt T., Aruffo A., Ledbetter J. A., Noelle R. J. The regulation of the expression of gp39, the CD40 ligand, on normal and cloned CD4+ T cells. J. Immunol. 1993; 151: 2497–2510
   PubMed Web of Science ®Google Scholar
• Fuleihan R., Ahern D., Geha R. S. Expression of the CD40 ligand in T lymphocytes and induction of IgE isotype switching. Int. Arch. Allergy Immunol. 1995; 107: 43–44
   PubMed Web of Science ®Google Scholar
• Yellin M. J., Sippel K., Inghirami G., Covey L. R., Lee J. J., Sinning J., Clark E. A., Chess L., Lederman S. CD40 molecules induce down-modulation and endo-cytosis of T cell surface T cell-B cell activating molecule/CD40L. Potential role in regulating helper effector function. J. Immunol. 1994; 152: 598–608
   PubMed Web of Science ®Google Scholar
• Lederman S., Yellin M. J., Inghirami G., Lee J. J., Knowles D. M., Chess L. Molecular interactions mediating T-B lymphocyte collaboration in human lymphoid follicles. J. Immunol. 1992; 149: 3817–3826
   PubMed Web of Science ®Google Scholar
• van den Eertwegh A. J. M., Noelle R. J., Roy M., Shepherd D. M., Aruffo A., Ledbetter J. A., Bocrsma W. J. A., Claassen E. CD40-gp39 interactions are essential for thymus dependent humoral immunity and identify sites of cognate interactions in vivo. J. Exp. Med. 1993; 178: 1555–1565
   PubMed Web of Science ®Google Scholar
• Gauchat J.-F., Henchoz S., Mazzei G., Aubry J.-P., Brunner T., Blasey H., Life P., Talabot D., Flores-Romo L., Thompson J., Kishi K., Butterfield J., Dahinden C., Bonnefoy J.-Y. Induction of human IgE synthesis in B cells by mast cells and basophils. Nature 1993; 365: 340–343
   PubMed Web of Science ®Google Scholar
• Gauchat J.-F., Henchoz S., Fattah D., Mazzei G., Aubry J.-P., Jomotte T., Dash L., Page K., Solari R., Aldebert D., Capron M., Dahinden C., Boonefoy J.-Y. CD40 ligand is functionally expressed on human eosinophils. Eur. J. Immunol. 1995; 25: 863–865
   PubMed Web of Science ®Google Scholar
• Ware C. F., Crowe P. D., Vanarsdale T. L., Andrews J. L., Grayson M. H., Jerzy R., Smith C. A., Goodwin R. G. Tumor necrosis factor (TNF) receptor expression in T lymphocytes. Differential regulation of the type I TNF receptor during activation of resting and effector T cells. J. Immunol. 1991; 147: 4229–4238
   PubMed Web of Science ®Google Scholar
• Armitage R. J., Maliszewski C. R., Alderson M. R., Grabstein K. H., Spriggs M. K., Fanslow W. C. CD40L: A multi-functional ligand. Semin. Immunol. 1993; 5: 401–412
   PubMedGoogle Scholar
• Armitage R. J., Tough T. W., Macduff B. M., Fanslow W. C., Spriggs M. K., Ramsdell F., Alderson M. R. CD40 ligand is a T cell growth factor. Eur. J. Immunol. 1993; 23: 2326–2331
   PubMed Web of Science ®Google Scholar
• Fanslow W. C., Clifford K. N., Seaman M., Alderson M. R., Spriggs M. K., Armitage R. J., Ramsdell F. Recombinant CD40 ligand exerts potent biologic effects on T cells. J. Immunol. 1994; 152: 4262–4269
   PubMed Web of Science ®Google Scholar
• Ramsdell F., Seaman M., Clifford K. N., Fanslow W. C. CD40 ligand acts as a costimulatory signal for neonatal thymic γδ T cells. J. Immunol. 1994; 152: 2190–2197
   PubMed Web of Science ®Google Scholar
• Splawski J. B., Nishioka J., Nishioka Y., Lipsky P. E. CD40 ligand is expressed and functional on activated neonatal T cells. J. Immunol. 1996; 156: 119–127
   PubMed Web of Science ®Google Scholar
• Cayabyab M., Phillips J. H., Lanier L. L. CD40 preferentially costimulates activation of CD4+ T lymphocytes. J. Immunol. 1994; 152: 1523–1531
   PubMed Web of Science ®Google Scholar
• Grewal I. S., Xu J., Flavell R. A. Impairment of antigen-specific T-cell priming in mice lacking CD40 ligand. Nature 1995; 378: 617–620
   PubMed Web of Science ®Google Scholar
• van Essen D., Kikutani H., Gray D. CD40 ligand-transduced co-stimulation of T cells in the development of helper function. Nature 1995; 378: 620–623
   PubMed Web of Science ®Google Scholar
• Le J., Vilcek J. Tumor necrosis factor and interleukin 1987; 1, cytokines with multiple overlapping biological activities. Lab. Invest.; 56:234–248
   Google Scholar
• Landis R. C., Friedman M. L., Fisher R. I., Ellis T. M. Induction of human monocyte IL-1 mRNA and secretion during anti-CD3 mitogenesis requires two distinct T cell-derived signals. J. Immunol. 1991; 146: 128–135
   PubMed Web of Science ®Google Scholar
• Webb D. S., Shimizu Y., Van Seventer G. A., Shaw S., Gerrard T. L. LFA-3, CD44, and CD45: physiologic triggers of human monocyte TNF and IL-1 release. Science 1990; 249: 1295–1297
   PubMed Web of Science ®Google Scholar
• Alderson M. R., Armitage R. J., Tough T. W., Strockbine L., Fanslow W. C., Spriggs M. K. CD40 expression by human monocytes: Regulation by cytokines and activation of monocytes by the ligand for CD40. J. Exp. Med. 1993; 178: 669–674
   PubMed Web of Science ®Google Scholar
• Kiener P. A., Moran-Davis P., Rankin B. M., Wahl A. F., Aruffo A., Hollenbaugh D. Stimulation of CD40 with purified soluble gp39 induces proinflammatory responses in human monocytes. J. Immunol. 1995; 155: 4917–4925
   PubMed Web of Science ®Google Scholar
• Wagner D. H., Stout R. D., Suttles J. Role of the CD40-CD40 ligand interaction in CD4+ T cell contact-dependent activation of monocyte interleukin-1 synthesis. Eur. J. Immunol. 1994; 24: 3148–3154
   PubMed Web of Science ®Google Scholar
• Shu U., Kiniwa M., Wu C. Y., Maliszewski C., Vezzio N., Hakimi J., Gately M., Delespesse G. Activated T cells induce interleukin-12 production by monocytes via CD40-CD40 ligand interaction. Eur. J. Immunol. 1995; 25: 1125–1128
   PubMed Web of Science ®Google Scholar
• Stout R. D., Suttles J. Xu. J., Grewal I. S., Flavell R. A. Impaired T cell-mediated macrophage activation in CD40 ligand-deficient mice. J. Immunol. 1996; 156: 8–11
   PubMed Web of Science ®Google Scholar
• Moreau I., Duvert V., Banchereau J., Saeland S. Culture of human fetal B-cell precursors on bone marrow stroma maintains highly proliferative CD20dim cells. Blood 1993; 81: 1170–1178
   PubMed Web of Science ®Google Scholar
• Saeland S., Duvert V., Caux C., Pandrau D., Favre C., Valle A., Durand I., Charbord P., de Vries J., Bancherau J. Distribution of surface-membrane molecules on bone marrow and cord blood CD34+ hematopoietic cells. Exp. Hematol. 1992; 20: 24–29
   PubMed Web of Science ®Google Scholar
• Saeland S., Duvert V., Moreau I., Banchereau J. Human B cell precursors proliferate and express CD23 after CD40 ligation. J. Exp. Med. 1993; 178: 113–120
   PubMed Web of Science ®Google Scholar
• Renard N., Duvert V., Blanchard D., Banchereau J., Saeland S. Activated CD4+ T cells induce CD40-dependent proliferation of human B cell precursors. J. Immunol. 1994; 152: 1693–1701
   PubMed Web of Science ®Google Scholar
• Caux C., Yong-Jun L., Banchereau J. Recent advances in the study of dendritic cells and follicular dendritic cells. Immunol. Today 1995; 16: 2–4
   PubMedGoogle Scholar
• Vyth-Dreese F. A., Dellemijn T. A., Majoor D., de Jong D. Localization in situ of the co-stimulatory molecules B7.1, B7.2, CD40 and their ligands in normal human lymphoid tissue. Eur. J. Immunol. 1995; 25: 3023–3029
   PubMed Web of Science ®Google Scholar
• Pequet-Navarro J., Dalbiez-Gauthier C., Rattis F. M., van Kooten C., Banchereau J., Schmitt D. Functional expression of CD40 antigen on human epidermal Langerhans cells. J. Immunol. 1995; 155: 4241–4247
   PubMed Web of Science ®Google Scholar
• Romani N., Lenz A., Glassl H., Stossel H., Stanzl U., Majdic O., Fritsch P., Schuler G. Cultured human Langerhans cells resemble lymphoid dendritic cells in phenotype and function. J. Invest. Dermatol. 1989; 93: 600–609
   PubMed Web of Science ®Google Scholar
• Caux C., Dezutter-Dambuyant C., Smitt D., Banchereau J. GM-CSF and TNF-α cooperate in the generation of dendritic Langerhans cells. Nature 1992; 360: 258–261
   PubMed Web of Science ®Google Scholar
• Caux C., Massacrier C., Vanbervliet B., Dubois B., Van Kooten C., Durand I., Banchereau J. Activation of human dendritic cells through CD40 cross-linking. J. Exp. Med. 1994; 180: 1263–1272
   PubMed Web of Science ®Google Scholar
• Clark E. A., Grabstein K. H., Shu G. L. Cultured human follicular dendritic cells. Growth characteristics and interactions with B lymphocytes. J. Immunol. 1992; 148: 3327–3335
   PubMed Web of Science ®Google Scholar
• Schriever F., Freedman A. S., Freeman G., Messner E., Lee G., Daley J., Nadler L. M. Isolated human follicular dendritic cells display a unique antigenic phenotype. J. Exp. Med. 1989; 169: 2043–2058
   PubMed Web of Science ®Google Scholar
• Gray D. Immunological memory. Annu. Rev. Immunol. 1993; 11: 49–77
   PubMed Web of Science ®Google Scholar
• Lenschow D., Bluestone J. T cell co-stimulation and in vivo tolerance. Curr. Opin. Immunol. 1993; 5: 747–752
   PubMed Web of Science ®Google Scholar
• June C., Bluestone J., Nadler L., Thompson C. The B7 and CD28 receptor families. Immunol. Today 1994; 15: 321–331
   PubMedGoogle Scholar
• Durie F. H., Foy T. M., Masters S. R., Laman J. D., Noelle R. J. The role of CD40 in the regulation of humoral and cell-mediated immunity. Immunol. Today 1994; 15: 406–411
   PubMedGoogle Scholar
• Springer T. A. Traffic signals for lymphocyte recirculation and leukocyte emigration: the multi-step paradigm. Cell 1994; 76: 301–314
   PubMed Web of Science ®Google Scholar
• Carlos T. M., Harlan J. M. Leukocyte-endothelial adhesion molecules. Blood 1994; 84: 2068–2101
   PubMed Web of Science ®Google Scholar
• Yellin M. J., Brett J., Baum D., Matsushima A., Szabolcs M., Stern D., Chess L. Functional interactions of T cells with endothelial cells: the role of CD40L-CD40-mediated signals. J. Exp. Med. 1995; 182: 1857–1864
   PubMed Web of Science ®Google Scholar
• Hollenbaugh D., Mischel-Petty N., Edwards C. P., Simon J. C., Denfeld R. W., Kiener P. A., Aruffo A. Expression of functional CD40 by vascular endothelial cells. J. Exp. Med. 1995; 82: 33–40
   Web of Science ®Google Scholar
• Karmann K., Hughes C. C. W., Schechner J., Fanslow W. C., Pober J. S. CD40 on human endothelial cells: inducibility by cytokines and functional regulation of adhesion molecule expression. Proc. Natl. Acad. Sci. USA 1995; 92: 4342–4346
   PubMed Web of Science ®Google Scholar
• Karmann K., Hughes C. C. W., Fanslow W. C., Pober J. S. Endothelial cells augment the expression of CD40 ligand on newly activated human CD4+ T cells through a CD2/LFA-3 signaling pathway. Eur. J. Immunol. 1996; 26: 610–617
   PubMed Web of Science ®Google Scholar
• Galy A. H. M., Spits H. CD40 is functionally expressed on human thymic epithelial cells. J. Immunol. 1992; 149: 775–782
   PubMed Web of Science ®Google Scholar
• Foy T. M., Page D. M., Waldschmidt T. J., Schoneveld A., Laman J. D., Masters S. R., Tygrett L., Ledbetter J. A., Aruffo A., Claassen E., Xu J. C., Flavell R. A., Oehen S., Hedrick S. M., Noelle R. J. An essential role for gp39, the ligand for CD40, in thymic selection. J. Exp. Med. 1995; 182: 1377–1388
   PubMed Web of Science ®Google Scholar
• Hess S., Engelmann H. A novel function of CD40: induction of cell death in transformed cells. J. Exp. Med. 1996; 183: 159–167
   PubMed Web of Science ®Google Scholar
• Fraser J., Straus D., Weiss A. Signal transduction events leading to T-cell lymphokine gene expression. Immunol. Today 1993; 14: 357–362
   PubMedGoogle Scholar
• Inghirami G., Lederman S., Yellin M. J., Chadburn A., Chess L., Knowles D. M. Phenotypic and functional characterization of T-BAM (CD40 ligand) T-cell non-Hodgkin's lymphoma. Blood 1994; 84: 866–872
   PubMed Web of Science ®Google Scholar
• Carbone A., Gloghini A., Gruss H.-J., Pinto A. CD40 ligand is constitutively expressed in a subset of T-cell lymphomas and on the microenvironmental reactive T-cells of follicular lymphomas and Hodgkin's disease. Am. J. Pathol. 1995; 147: 912–922
   PubMed Web of Science ®Google Scholar
• Dijkstra N. H., Planken E. V., Bakkus M., Willemze R., Kluin-Nelemans J. C. Proliferation of precursor B-ALL by triggering the CD40 antigen. Blood 1995; 86, (Suppl. 1) 174a, 684
   Web of Science ®Google Scholar
• Renards N., Durand I., Duvert V., Coignet L., Lafage-Pochitaloff M., Banchereau J., Saeland S. Activated CD4+ T cells can induce CD40-dependent proliferation and maturation of B lineage acute lymphoblastic leukemia cells. Blood 1995; 86, (Suppl. 1) 776a, 3092
   Web of Science ®Google Scholar
• Francisco J. A., Gilliland L. K., Stebbins M. R., Norris N. A., Ledbetter J. A., Siegall C. B. Activity of a single-chain immunotoxin that selectively kills lymphoma and other B-lineage cells expressing the CD40 antigen. Cancer Res. 1995; 55: 3099–3104
   PubMed Web of Science ®Google Scholar
• Carbone A., Gloghini A., Gattei V., Aldinucci D., Degan M., Paoli P. D., Zagonel V., Pinto A. Expression of functional CD40 antigen on Reed-Sternberg cells and Hodgkin's disease cell lines. Blood 1995; 85: 780–789
   PubMed Web of Science ®Google Scholar
• Schlaifer D., Krajewski S., Rigal-Huguet F., Meggetto F., Pris J., Massip P., Laurent G., Marchou B., Delsol G., Reed J. C., Brousset P. Expression of apoptosis-regulating genes in AIDS-related lymphomas. Blood 1995; 86, (Suppl. 1) 380a, 1508
   Web of Science ®Google Scholar
• Defrance T., Fluckiger A. N., Rossi J. F., Rousset F., Banchereau J. In vitro activation of B-CLL cells. Leuk. Lymphoma 1991; 7: 13–19
   Web of Science ®Google Scholar
• Crawford D. H., Catovsky D. In vitro activation of leukemic B-cells by interleukin-4 and antibodies to CD40. Imunology 1993; 80: 40–44
   PubMed Web of Science ®Google Scholar
• Johnson P. W. M., Watt S. M., Betts D. R., Davies D., Jordan S., Norton A. J., Lister T. A. Isolated follicular lymphoma cells are resistant to apoptosis and can be grown in vitro in the CD40/stromal cell system. Blood 1993; 82: 1848–1857
   PubMed Web of Science ®Google Scholar
• Umetsu D. T., Esserman L., Donlon T. A., DeKruyff R. H., Levy R. Induction of proliferation of human follicular (B type) lymphoma cells by cognate interaction with CD4+ T cell clone. J. Immunol. 1990; 144: 2550–2557
   PubMed Web of Science ®Google Scholar
• Kluin-Nelemans H. C., Baverstock G. C., Mollevanger P., Wessels H. W., Hoogendorn E., Willemze R., Falkenburg J. H. F. Proliferation and cytogenetic analysis of hairy cell leukemia upon stimulation via the CD40 antigen. Blood 1994; 84: 3134–3141
   PubMed Web of Science ®Google Scholar
• Panayiotidis P., Ganeshaguru K., Jabbar S. A., Hoffbrand A. V. Interleukin-4 inhibits apoptotic cell death and loss of the bcl-2 protein in B-chronic lymphocytic leukaemia cells in vitro. Br. J. Haematol. 1993; 85: 439–445
   PubMed Web of Science ®Google Scholar
• Ranheim E. A., Kipps T. J. Tumor necrosis factor-α facilitates induction of CD80 (B7-1) and CD54 on human B cells by activated T-cells: complex regulation by IL-4, IL-10, and CD40L. Cell. Immunol. 1995; 161: 226–235
   PubMed Web of Science ®Google Scholar
• Lotz M., Ranheim E., Kipps T. J. Transforming growth factor beta as endogenous growth inhibitor of chronic lymphocytic leukemia B cells. J. Exp. Med. 1994; 179: 999–1004
   PubMed Web of Science ®Google Scholar
• Funakoshi S., Longo D. L., Beckwith M., Conley D. K., Tsarfaty G., Tsarfaty I., Armitage R. J., Fanslow W. C., Spriggs M. K., Murphy W. J. Inhibition of human B-cell lymphoma growth by CD40 stimulation. Blood 1994; 83: 2787–2794
   PubMed Web of Science ®Google Scholar
• Sumimoto S.-I., Heike T., Kanazashi S.-I., Shintaku N., Jung E.-Y., Hata D., Katamura K., Mayumi M. Involvement of LFA-1/intracellular adhesion molecule-1-dependent cell adhesion in CD40-mediated inhibition of human B lymphoma cell death induced by surface IgM crosslinking. J. Immunol. 1994; 153: 2488–2496
   PubMed Web of Science ®Google Scholar
• Funakoshi S., Longo D. L., Asai O., Beckwith M., Klinke R., Fanslow W. C., Murphy W. J. Inhibition of aggressive histology human B-cell lymphoma growth by soluble recombinant human CD40 ligand. Blood 1995; 86, (Suppl. 1) 602a, 2397
   PubMed Web of Science ®Google Scholar
• Fluckiger A.-C., Durand I., Banchereau J. Interleukin 10 induces apoptotic death of B-chronic lymphocytic leukemia cells. J. Exp. Med. 1994; 179: 91–99
   PubMed Web of Science ®Google Scholar
• Jackson N., Ling N. R., Ball J., Bromidge E., Nathan P. D., Franklin I. M. An analysis of myeloma plasma cell phenotype using antibodies defined at the IIIrd international workshop on human leucocyte differentiation antigens. Clin. Exp. Immunol. 1988; 72: 351–356
   PubMed Web of Science ®Google Scholar
• Hamilton M. S., Ball J., Bromidge E., Franklin I. M. Surface antigen expression of human neoplastic plasma cells includes molecules associated with lymphocyte recirculation and adhesion. Br. J. Haematol. 1991; 78: 60–65
   PubMed Web of Science ®Google Scholar
• Westendorf J. J., Ahmann G. J., Armitage R. J., Spriggs M. K., Lust J. A., Greipp P. R., Katzmann J. A., Jelinek D. F. CD40 expression in malignant plasma cells—role in stimulation of autocrine IL-6 secretion by a human myeloma cell line. J. Immunol. 1994; 152: 117–128
   PubMed Web of Science ®Google Scholar
• Pellat-Deceunynck C., Bataille R., Robillard N., Harosseau J.-L., Rapp M.-J. Expression of CD28 and CD40 in human myeloma cells: a comparative study with normal plasma cells. Blood 1994; 84: 2597–2603
   PubMed Web of Science ®Google Scholar
• Tong A. W., Zhang B.-Q., Mues G., Solano M., Hanson T., Stone M. J. Anti-CD40 antibody binding modulates human multiple myeloma clonogenecity in vitro. Blood 1994; 84: 3026–3033
   PubMed Web of Science ®Google Scholar
• Urashima M., Chauhan D., Uchiyama H., Freeman G. J., Anderson K. C. CD40 ligand triggered interleukin-6 secretion in multiple myeloma. Blood 1995; 85: 1903–1912
   PubMed Web of Science ®Google Scholar
• Westendorf J. J., Ahmann G. J., Lust J. A., Tschumper R. C., Greipp P. R., Katzmann J. A., Jelinek D. F. Molecular and biological role of CD40 in multiple myeloma. Curr. Top. Microbiol. Immunol. 1995; 194: 63–72
   PubMedGoogle Scholar
• Carbone A., Gloghini A., Zagonel V., Aldinucci D., Gattei V., Degan M., Improta S., Sorio R., Monfardini S., Pinto A. The expression of CD26 and CD40L is mutually exclusive in human T-cell non-Hodgkin's lymphomas/leukemias. Blood 1995; 86: 4617–4626
   PubMed Web of Science ®Google Scholar
• Armitage R. J., Macduff B. M., Fanslow W. C. Distinct patterns of inhibition by CD40 mAb of the CD40 ligand: CD40 interaction. Leucocyte Typing V, S. F. Schlossman, L. Boumsell, W. Gilks, J. M. Harlan, T. Kishimoto, C. Morimoto, J. Ritz, S. Shaw, R. Silverstein, T. Springer, T. F. Tedder, R. F. Todd. Oxford University Press, Oxford 1995; 551–552
   Google Scholar
• Casamayor-Palleja M., Khan M., MacLennan I. C. M. A subset of CD4+ memory T cells contains preformed CD40 ligand that is rapidly but transiently expressed on their surface after activation through the T cell receptor complex. J. Exp. Med. 1995; 181: 1293–1301
   PubMed Web of Science ®Google Scholar
• Borowitz M. J., Weidner A., Olsen E. A., Picker L. J. Abnormalities of circulating T-cell subpopulations in patients with cutaneous T-cell lymphoma: cutaneous lymphocyte-associating antigen expression on T cells correlates with extent of disease. Leukemia 1993; 7: 859–863
   PubMed Web of Science ®Google Scholar
• Nagatani T., Matsuzaki T., Iemoto G., Kim S., Baba N., Miyamoto H., Nakajima H. Comparative study of cutaneous T-cell lymphoma and adult T-cell leukemia/lymphoma. Clinical, histopathologic, and immunohistochemical analysis. Cancer 1990; 66: 2380–2386
   PubMed Web of Science ®Google Scholar
• DeCoteau J. F., Kadin M. E. New insights into peripheral T-cell lymphomas. Curr. Opin. Oncol. 1995; 7: 408–414
   PubMedGoogle Scholar
• Pinto A., Aldinucci D., Carbone A., Gattei V., Zagonel V., Improta S., Degan M., De Juliis A., Gloghini A., Gruss H.-J. Identification of a novel subset of human acute myeloid leukemias expressing CD40 and showing a proliferative response to CD40 ligand. Blood 1996, Submitted
   Google Scholar
• Gruss H.-J., Liedtke M., Armitage R. J., Pinto A., Herrmann F., Ludwig W.-D. Frequent functional coexpression of CD40 and CD30L on acute lymphoblastic leukemia cells. Blood 1996, Submitted
   Google Scholar
• Reid C. D. L., Fryer P. R., Clifford C., Kirk A., Tikerpae J., Knight S. C. Identification of hematopoietic progenitors of macrophage and dendritic Langerhans cells (DL-CFU) in human bone marrow and peripheral blood. Blood 1990; 76: 1139–1149
   PubMed Web of Science ®Google Scholar
• Reid C. D. L., Stackpole A., Meager A., Tikerpae J. Interactions of tumor necrosis factor with granulocyte-macrophage colony-stimulating factor and other cytokines in the regulation of dendritic cell growth in vitro from early bipotent CD34+ progenitors in human bone marrow. J. Immunol. 1992; 149: 2681–2688
   PubMed Web of Science ®Google Scholar
• Romani N., Gruner S., Brang D., Kämpgen E., Lenz A., Trockenbacher B., Konwalinka G., Fritsch P. O., Steinmann R. M., Schuler G. Proliferating dendritic cell progenitors in human blood. J. Exp. Med. 1994; 180: 83–93
   PubMed Web of Science ®Google Scholar
• Young L. W., Szabolcs P., Moore M. A. S. Identification of dendritic cell colony-forming units among normal human CD34+ bone marrow progenitors that are expanded by c-kit ligand and yield pure dendritic cell colonies in the presence of granulocyte/macrophage colony-stimulating factor and tumor necrosis factor-α. J. Exp. Med. 1995; 182: 1111–1120
   PubMed Web of Science ®Google Scholar
• Santiago-Schwarz F., Coppock D. L., Hindenburg A. A., Kern J. Identification of a malignant counterpart of the monocyte-dendritic cell progenitor in an acute myeloid leukemia. Blood 1994; 84: 3054–3062
   PubMed Web of Science ®Google Scholar
• Asimakopulos F. A., White N. J., Nacheva E. P., Green A. R. Molecular analysis of chromosome 20 deletions associated with myeloproliferative disorders and myelodysplastic syndromes. Blood 1994; 84: 3086–3094
   PubMed Web of Science ®Google Scholar
• Asimakopulos F. A., White N. J., Nacheva E. P., Green A. R. The human CD40 gene lies within chromosome 20q deletions associated with myeloid malignancies. Br. J. Haematol. 1996; 92: 127–130
   PubMed Web of Science ®Google Scholar
• Kennedy I. C., Hart D. N., Colls B. M., Nimmo J. C., Willis D. A., Angus H. B. Nodular sclerosing, mixed cellularity and lymphocyte-depleted variants of Hodgkin's disease are probable dendritic cell malignancies. Clin. Exp. Immunol. 1989; 76: 324–331
   PubMed Web of Science ®Google Scholar
• Gruss H.-J., Herrmann F., Drexler H. G. Hodgkin's disease: a cytokine producing tumor. Crit. Rev. Oncogenesis 1994; 5: 473–538
   PubMed Web of Science ®Google Scholar
• Gruss H.-J., Hirschstein D., Wright B., Ulrich D., Caligiuri M. A., Barcos M., Strockbine L., Armitage R. J., Dower S. K. Expression and function of CD40 on Hodgkin and Reed-Sternberg cells and the possible relevance for Hodgkin's disease. Blood 1994; 84: 2305–2314
   PubMed Web of Science ®Google Scholar
• Schwab U., Stein H., Gerdes J., Lemke H., Kirchner H., Schaadt M., Diehl V. Production of a monoclonal antibody specific for Hodgkin and Sternberg-Reed cells of Hodgkin's disease and a subset of normal lymphoid cells. Nature 1982; 299: 65–67
   PubMed Web of Science ®Google Scholar
• Falini B., Pileri S., Pizzolo G., Dñrkop H., Flenghi L., Stirpe F., Martelli M. F., Stein H. CD30 (Ki-1) molecule: a new cytokine receptor of the tumor necrosis factor receptor superfamily as a tool for diagnosis and immunotherapy. Blood 1995; 85: 1–14
   PubMed Web of Science ®Google Scholar
• O'Grady J. T., Stewart S., Lowrey J., Howie S. E., Krajewski A. S. CD40 expression in Hodgkin's disease. Am. J. Pathol. 1994; 144: 21–26
   PubMed Web of Science ®Google Scholar
• Carbone A., Gloghini A., Gruss H.-J., Pinto A. CD40 antigen expression on Reed-Sternberg cells. A reliable diagnostic tool for Hodgkin's disease. Am. J. Pathol. 1995; 146: 780–781
   PubMed Web of Science ®Google Scholar
• Murray P. G., Oates J., Reynolds G. M., Crocker L., Young L. S. Expression of B7 (CD80) and CD40 antigen and the CD40 ligand in Hodgkin's disease is independent of latent Epstein-Barr virus infection. J. Clin. Pathol. Mol. Pathol. 1995; 48: 105–108
   PubMed Web of Science ®Google Scholar
• Nadali G., Vinante F., Ambrosetti A., Todeschini G., Veneri D., Zanotti R., Meneghini V., Ricetti M. M., Benedetti F., Vassanelli A., Perona G., Chilosi M., Menestrina F., Fiacchini M., Stein H., Pizzolo G. Serum levels of soluble CD30 are elevated in the majority of untreated patients with Hodgkin's disease and correlate with clinical features and prognosis. J. Clin. Oncol. 1994; 12: 793–797
   PubMed Web of Science ®Google Scholar
• Gruss H.-J., Ulrich D., Dölken G., Armitage R. J., Herrmann F., Pinto A. Release of soluble CD40 antigen by Hodgkin's disease cells. Eur. J. Immunol. 1996, Submitted
   Google Scholar
• Gruss H.-J., Ulrich D., Braddy S., Armitage R. J., Dower S. K. Recombinant CD30 ligand and CD40 ligand share common biological activities on Hodgkin and Reed-Sternberg cells. Eur. J. Immunol. 1995; 25: 2083–2089
   PubMed Web of Science ®Google Scholar
• Chittal S. M., Caveriviere P., Schwarting R., Gerdes J., Al Saati T., Rigal-Huguet F., Stein H., Delsol G. Monoclonal antibodies in the diagnosis of Hodgkin's disease: the search for a rational panel. Am. J. Surg. Pathol. 1988; 12: 9–21
   PubMed Web of Science ®Google Scholar
• Carbone A., Gloghini A., Volpe R. Paraffin section immunohistochemistry in the diagnosis of Hodgkin's disease and anaplastic large cell (CD30+) lymphomas. Virchows Arch. A Pathol. Anat. Histopathol. 1992; 420: 527–532
   PubMedGoogle Scholar
• Drexler H. G. Recent results on the biology of Hodgkin and Reed-Sternberg cells. I. Biopsy material. Leuk. Lymphoma 1992; 8: 283–313
   PubMed Web of Science ®Google Scholar
• Medeiros J. L., Lardelli P., Stetler-Stevenson M., Longo D. L., Jaffe E. S. Genotypic analysis of diffuse. mixed cell lymphomas. Am. J. Clin. Pathol. 1991; 95: 547–555
   PubMed Web of Science ®Google Scholar
• Mirchandani I., Palutke M., Tabaczka P., Goldfarb S., Eisenberg L., Pak M. S. B-cell lymphomas morphologically resembling T-cell lymphomas. Cancer 1985; 56: 1578–1583
   PubMed Web of Science ®Google Scholar
• Osborne B. M., Butler J. J., Pugh W. C. The value of immunophenotyping on paraffin sections in the identification of T-cell rich B-cell large-cell lymphomas: lineage confirmed by JH rearrangement. Am. J. Surg. Pathol. 1990; 14: 933–938
   PubMed Web of Science ®Google Scholar
• Ramsay A. D., Smith W. J., Isaacson P. G. T-cell-rich B-cell lymphoma. Am. J. Surg. Pathol. 1988; 12: 433–443
   PubMed Web of Science ®Google Scholar
• Scarpa A., Bonetti F., Zamboni G., Menestrina F., Chilosi M. T-cell-rich B-cell lymphoma. Am. J. Surg. Pathol. 1989; 13: 335–337
   PubMed Web of Science ®Google Scholar
• Stein H., Mason D. Y., Gerdes J., O'Connor N., Wainscoat J., Pallesen G., Gatter K., Falini B., Delsol G., Lemke H., Schwarting R., Lennert K. The expression of the Hodgkin's disease associated antigen Ki-1 in reactive and neoplastic lymphoid tissue: evidence that Reed-Sternberg cells and histiocytic malignancies are derived from activated lymphoid cells. Blood 1985; 66: 848–858
   PubMed Web of Science ®Google Scholar
• Merz H., Houssiau F. A., Orscheschek K., Renauld J. C., Fliedner A., Herin M., Noel H., Kadin M., Mñller-Hermelink H.-K., Van Snick J., Feller A. C. Interleukin-9 expression in human malignant lymphomas: unique association with Hodgkin's disease and large cell anaplastic lymphoma. Blood 1991; 78: 1311–1317
   PubMed Web of Science ®Google Scholar
• Delabie J., Shipman R., Bruggen J., De Strooper B., van Leuven F., Tarcsay L., Cerletti N., Odink K., Diehl V., Bilbe G., De Wolf-Peeters C. Expression of the novel intermediate filament-associated protein restin in Hodgkin's disease and anaplastic large-cell lymphoma. Blood 1992; 80: 2891–2896
   PubMed Web of Science ®Google Scholar
• Pinto A., Gloghini A., Gattei V., Aldinucci D., Zagonel V., Carbone A. Expression of the c-kit receptor in human lymphomas is restricted to Hodgkin's disease and CD30+ anaplastic large cell lymphomas. Blood 1994; 83: 785–792
   PubMed Web of Science ®Google Scholar
• Rosso R., Paulli M., Magrini U., Kindl S., Boveri E., Volpato G., Poggi S., Baglioni P., Pileri S. Anaplastic large cell lymphoma, CD30/Ki-1 positive, expressing the CD15/Leu-M1 antigen. Virchows Arch. A Pathol. Anat. Histopathol. 1990; 416: 229–235
   PubMedGoogle Scholar
• Carbone A., Cozzi M., Gloghini A., Pinto A. CD26/DPPIV expression in human lymphomas is restricted to CD30-positive anaplastic large cell and a subset of T-cell non-Hodgkin's lymphomas. Hum. Pathol. 1994; 25: 1360–1365
   PubMed Web of Science ®Google Scholar
• Carbone A., Gloghini A., Zagonel V., Pinto A. An update on the diagnostic relevance of CD26 antigen expression in CD30 positive anaplastic large cell lymphomas. Hum. Pathol. 1995; 26: 1169–1170
   PubMed Web of Science ®Google Scholar
• Nishioka Y., Lipsky P. E. The role of CD40-CD40 ligand interaction in human T cell-B cell collaboration. J. Immunol. 1994; 153: 1027–1036
   PubMed Web of Science ®Google Scholar
• Kñppers R., Rajewsky K., Zhao M., Simons G., Laumann R., Fischer R., Hansmann M.-L. Hodgkin disease: Hodgkin and Reeed-Sternberg cells picked from histological sections show clonal immunoglobulin gene rearrangements and appear to be derived from B cells at various stages of development. Proc. Natl. Acad. Sci. USA 1994; 91: 10962–10966
   PubMed Web of Science ®Google Scholar
• Delabie J., Tierens A., Wu G., Weisenburger D. D., Chan W. C. Lymphocyte predominance Hodgkin's disease: lineage and clonality determination using a single-cell assay. Blood 1994; 84: 3291–3298
   PubMed Web of Science ®Google Scholar
• Hummel M., Ziemann K., Lammert H., Pileri S., Sabattini E., Stein H. Hodgkin's disease with monoclonal and polyclonal populations of Reed-Sternberg cells. N. Engl. J. Med. 1995; 333: 901–906
   PubMed Web of Science ®Google Scholar